Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Land & Improvements (2016 - 2024)

Angiodynamics (ANGO) has disclosed Land & Improvements for 13 consecutive years, with $493000.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Land & Improvements changed 0.0% year-over-year to $493000.0, compared with a TTM value of $493000.0 through May 2024, changed 0.0%, and an annual FY2024 reading of $493000.0, changed 0.0% over the prior year.
  • Land & Improvements was $493000.0 for Q2 2024 at Angiodynamics, roughly flat from $493000.0 in the prior quarter.
  • Across five years, Land & Improvements topped out at $493000.0 in Q2 2022 and bottomed at $472000.0 in Q2 2020.
  • Average Land & Improvements over 5 years is $484600.0, with a median of $493000.0 recorded in 2022.
  • The sharpest move saw Land & Improvements tumbled 56.42% in 2020, then grew 4.45% in 2022.
  • Year by year, Land & Improvements stood at $472000.0 in 2020, then changed by 0.0% to $472000.0 in 2021, then rose by 4.45% to $493000.0 in 2022, then changed by 0.0% to $493000.0 in 2023, then changed by 0.0% to $493000.0 in 2024.
  • Business Quant data shows Land & Improvements for ANGO at $493000.0 in Q2 2024, $493000.0 in Q2 2023, and $493000.0 in Q2 2022.